Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
115 Leser
Artikel bewerten:
(0)

Castle Connolly Releases Castle Connolly 2025 Top Doctors

Finanznachrichten News

Represents more than 70,000 doctors, or top 7% of doctors in the U.S., all nominated by their peers

NEW YORK CITY, NEW YORK / ACCESSWIRE / January 15, 2025 / Castle Connolly today announced the release of Castle Connolly's 2025 Top Doctors. With 1 million practicing doctors in the United States, Castle Connolly carefully curated its list of more than 70,000 board-certified U.S. physicians, across all 50 states and 85 medical specialties.

Castle Connolly Top Doctors represent the top 7% of physicians nationwide, selected through a rigorous process that is based on peer nominations, professional achievements, and excellence in patient care. These doctors exemplify the highest standards of expertise and integrity, giving patients the confidence and guidance to make informed healthcare decisions. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.

"Today, trust is something you have to work on because it's no longer automatically assumed." said Michael Dowling, President and CEO of Northwell Health. "Patients have more information, they ask more questions, and they have more choices than ever before. Having more Castle Connolly Top Doctors than any other health system is a positive sign for patients, giving them more confidence in the care they receive."

As Castle Connolly announces its annual Top Doctors list for 2025, the role of trusted physicians has never been more important. Recent research by JAMA highlights a significant decline in public trust in physicians and hospitals in the U.S., with trust levels dropping from approximately 72% in April 2020 to just 40% as of January 2024. This decline spans all demographic groups and transcends political lines, reflecting a universal challenge in rebuilding trust within healthcare.

As trust in traditional healthcare institutions declines, patients have increasingly turned to online platforms to research doctors and explore their healthcare options. In fact, research has shown that as many as 80% of internet users seek health information online, including resources like Castle Connolly. Social media platforms have also become vital spaces where individuals not only share health-related information but also engage with peers for support and advice. As these platforms continue to thrive, they play a critical role in bridging gaps in understanding and empowering patients to make informed decisions.

"I've found social media to be instrumental in reaching people who may know nothing about certain areas of medicine," said Dr. Betsy Grunch, a neurosurgeon and Castle Connolly Top Doctor. "My hope is that the knowledge I share will empower them as they navigate their healthcare decisions." Dr. Grunch, also known as Ladyspinedoc, uses her online platforms to educate patients daily with case studies and relevant healthcare news, reaching over 4 million collective followers.

"We understand that patients are increasingly turning to online sources to make informed healthcare decisions," said Steve Leibforth, Managing Director of Castle Connolly. "Our Top Doctors list serves as a trusted tool, helping patients confidently navigate their healthcare journey by connecting them with leading medical professionals recognized for their expertise and commitment to excellence."

To further help patients find high-quality care, Castle Connolly will be announcing the 2025 Castle Connolly Accolades on January 28th, recognizing health systems, hospitals, and physician practices which provide an outstanding level of high quality healthcare through their top-ranked Castle Connolly Top Doctors. Accolades are awarded to institutions with the most Top Doctors in a specific service line or medical specialty.

About Castle Connolly

With over 30 years' experience researching, reviewing and selecting Top Doctors, Castle Connolly is a highly trusted and credible source. A study published in the Journal of Medical Research found that across several specialties evidence indicates that Castle Connolly's peer-reviewed directory is methodologically more reliable than sites that just relied on patient reviews when it came to identifying quality care. Our mission is to help people find the best healthcare by connecting patients with best-in-class healthcare providers. For more information, visit https://www.castleconnolly.com.

About Everyday Health Group

The Everyday Health Group is a recognized leader in patient and provider education, attracting an engaged audience of over 81 million health consumers and over 890,000 U.S. practicing physicians and clinicians to its premier health and wellness digital properties. Our mission is to drive better clinical and health outcomes through decision-making informed by highly relevant information, data and analytics. We empower healthcare providers and consumers with trusted content and services delivered through the Everyday Health Group's world-class brands. Everyday Health Group is a division of Ziff Davis, Inc. (NASDAQ: ZD).

Contact Information

Caroline Baron
Senior Director
publicrelations@castleconnolly.com
(212) 367-8400

.

SOURCE: Castle Connolly



View the original press release on accesswire.com

© 2025 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.